Research leads to more effective methods of treating drug addictions

December 18, 2000

Jonathan Freedman, Associate Professor of Pharmacology in the Department of Pharmaceutical Sciences at Northeastern University's Bouve College of Health Sciences, has discovered why people who suffer from drug addictions or chronic severe pain crave larger dosages of drug treatments over time.

The findings of Professor Freedman and his team resulted from a three-year project funded by the National Institute on Drug Abuse in Bethesda, Maryland. Freedman and his team discovered a specific molecular change in the brain, using a research method called "patch-clamp electrophysiology" on the surface of rat brain cells, one molecule at a time. They found that rats treated with morphine eventually needed higher dosages of drugs to achieve the same effect. Freedman and team hope this understanding will later give way to practical applications in human patients.

"Scientists have been looking for almost 30 years for the molecular mechanism of opiate drug tolerance," says Professor Freedman. "I hope that our discovery will be a significant step towards understanding it. Eventually, we may be better able to treat heroin addicts, and better able to help people like cancer patients who have chronic severe pain."

Professor Freedman's article, "Altered Gating of Opiate Receptor-Modulated K+ Channels on Amygdala Neurons of Morphine-Dependent Rats," was co-authored with Northeastern graduate students Xueguang Chen and Yong-Jian Lin and postdoctoral fellows Hector Marrero and Ricardo Murphy. The article was published in this week's Proceedings of the National Academy of Sciences.

Boston-based Northeastern University, a private research institution, is a world leader in practice-orientated education. Building on its flagship co-operative education program, Northeastern links classroom learning with workplace experience and integrates professional preparation with study in the liberal arts and sciences.

Representing a wide variety of cultural and ethnic groups, nearly 12,000 undergraduates come from throughout the United States and dozens of other countries to experience Northeastern's dynamic learning environment.
For copies of Professor Freedman's article, call Laura Schmidt at (617) 373-5739.

Northeastern University

Related Pharmaceutical Sciences Articles from Brightsurf:

GARDP partners with Japanese pharmaceutical in pursuit of new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) has today announced an agreement with Daiichi Sankyo for GARDP to access and screen the Daiichi Sankyo chemical library.

The integrated catalysts can simplify pharmaceutical manufacturing
Prof. In Su Lee and his research team from POSTECH developed catalytic platforms based on metal organic frameworks.

Study: Pharmaceutical companies marketing stimulants to physicians
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications.

3D printing with applications in the pharmaceutical industry
This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumour biomarkers.

Turning wood into pharmaceutical ingredients 
Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

Active pharmaceutical ingredients can persist in the environment
A study finds trace levels of medicines in drinking water from private wells.

Drug development stakeholders call for improved pharmaceutical testing
Published in Drug Discovery Today, 'Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing' identifies the necessary steps that will lead to safer and more effective medicines, guided by a greater focus on human-based in vitro and in silico methods, which allow scientists to observe human cells, tissues, and biological processes, and their interaction with potential medications.

A step ahead in pharmaceutical research
Researchers of the University of W├╝rzburg have developed a method that makes it possible to measure the activation of receptors in a very short time.

Are pharmaceutical marketing payments to physicians for opioids associated with prescribing?
Pharmaceutical industry marketing of opioid products to physicians through nonresearch payments, which can include speaking fees and meals, was associated with greater opioid prescribing.

Read More: Pharmaceutical Sciences News and Pharmaceutical Sciences Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to